Postmortem studies have revealed reduced densities of dendritic spines in the dorsal lateral prefrontal cortex (DLPFC) of subjects with schizophrenia. However, the molecular mechanisms that might contribute to these alterations are unknown. Recent studies of the intracellular signals that regulate spine dynamics have identified members of the RhoGTPase family (e.g., Cdc42, Rac1, RhoA) as critical regulators of spine structure. In addition, Duo and drebrin are spine-specific proteins that are critical for spine maintenance and spine formation, respectively. In order to determine whether the mRNA expression levels of Cdc42, Rac1, RhoA, Duo or drebrin are altered in schizophrenia, tissue sections containing DLPFC area 9 from 15 matched pairs of subjects with schizophrenia and control subjects were processed for in situ hybridization. Expression levels of these mRNAs were also correlated with DLPFC spine density in a subset of the same subjects. In order to assess the potential influence of antipsychotic medications on the expression of these mRNAs, similar studies were conducted in monkeys chronically exposed to haloperidol or olanzapine. The expression of each of these mRNAs was lower in the gray matter of the subjects with schizophrenia compared to the control subjects, although only the reductions in Cdc42 and Duo remained significant after corrections for multiple comparisons. In addition, spine density was strongly correlated with the expression levels of both Duo (r = 0.73, P = 0.007) and Cdc42 (r = 0.71, P = 0.009) mRNAs. In contrast, the expression levels of Cdc42 and Duo mRNAs were not altered in monkeys chronically exposed to antipsychotic medications. In conclusion, reduced expression of Cdc42 and Duo mRNAs may represent molecular mechanisms that contribute to the decreased density of dendritic spines in the DLPFC of subjects with schizophrenia.
Introduction
Postmortem studies have revealed somatodendritic abnormalities of pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. These abnormalities include smaller somal volumes, decreased dendritic arbor size and complexity, and reduced dendritic spine density on subpopulations of pyramidal neurons. [1] [2] [3] [4] [5] [6] [7] For example, spine density on the basilar dendrites of pyramidal neurons in deep layer 3 of the dorsolateral prefrontal cortex (DLPFC) is significantly lower in subjects with schizophrenia relative to both normal comparison subjects and individuals with other psychiatric disorders. 5 However, the molecular mechanisms that mediate these alterations in cellular morphology are unknown.
Recent advances in knowledge of the intracellular signals that regulate the formation and maintenance of dendritic spines provide the opportunity to examine the molecular pathways that may contribute to the reduction in dendritic spine density in schizophrenia. Members of the RhoGTPase family of small GTP-binding proteins play major roles in the intracellular signal transduction pathways that regulate the actin cytoskeleton, which is critical for diverse cellular functions in both neurons and glia. [8] [9] [10] In neurons, different members of the RhoGTPase family regulate different aspects of dendritic and spine morphology. 11, 12 For example, the RhoGTPase Cdc42 (cell division cycle 42), which regulates the outgrowth of the actin cytoskeleton, is involved in the formation of thin protrusions (filopodia), which may develop into mature spines. In neuronal cultures, Cdc42 is essential for the establishment of the full complement of dendritic spines. [13] [14] [15] Similarly, Rac1 (Ras-related C3 botulinum toxin substrate 1) helps stabilize the actin cytoskeleton, and thus appears to contribute to dendrite initiation, elongation and branching, as well as the outgrowth of spine-like structures, 13, 14 In hippocampal slice preparations, Rac1 has been shown to be a critical regulator of dendritic spine density. 16 In contrast, RhoA (Ras homologous member A) regulates the destabilization of the actin cytoskeleton, such that the activation of RhoA results in decreased dendritic growth and branching and a reduction in the density of dendritic spines. 14, 16 Thus, each of these RhoGTPase can be considered to play complementary roles in spine dynamics: Cdc42 contributes to spine formation, Rac1 is important in spine stability and maintenance and RhoA is involved in spine contraction. In addition, the substantial 'cross-talk' among these proteins (e.g., RhoA is inhibited by Cdc42 and is activated by Rac1, whereas RhoA inhibits Rac1) suggests that they interact in regulating spine density. 17 Two other proteins, Duo and drebrin, that are selectively localized to spines, also play roles in spine structure. Duo, the human ortholog of the murine Kalirin-7, is a GDP-GTP exchange factor that activates Rac1. 18 Duo is concentrated in the postsynaptic density of the spine head and interacts with several PDZ domain-containing proteins. 19 Transfection of individual hippocampal neurons with Duo antisense RNA results in a marked decrease in spine density, a dissociation of spines from presynaptic terminals and a substantial reduction in the number of postsynaptic densities. 20 Therefore, Duo appears to be essential for spine maintenance and for coordinating the apposition of presynaptic terminals to the sites of postsynaptic densities.
Drebrin, an actin-binding protein heavily localized to dendritic spines, 21 appears to be involved in spine morphogenesis by promoting the conversion of filopodia into mature spines. 22 In cultures of developing hippocampal neurons, drebrin clusters are present in virtually all spines and filopodia that receive synaptic inputs. Treatment with antisense oligonucleotides against drebrin attenuates the clustering of the postsynaptic density in filopodia at the site of synaptic inputs, whereas subsequent treatment with expression vectors for drebrin induces reclustering of the postsynaptic density. 22 These data suggest that drebrin regulates the maturation of filopodia into mature spines by promoting the formation of the postsynaptic density.
In order to determine whether alterations in the expression of one or more of these proteins might contribute to the reduced densities of dendritic spines in the DLPFC of subjects with schizophrenia, we examined the levels of Cdc42, Rac1, RhoA, Duo and drebrin mRNAs in 15 matched pairs of schizophrenia and normal comparison subjects. The laminar specificity of any changes in expression, and their association with spine density, were also determined. Finally, in order to assess the potential influence of antipsychotic medications on the expression of these mRNAs, similar studies were conducted in monkeys chronically exposed to haloperidol or olanzapine.
Materials and methods

Human subjects
The brain specimens used in this study were obtained at autopsies performed at the Allegheny County (PA) Coroner's Office, following consent from the next-ofkin and using procedures approved by the University of Pittsburgh's Institutional Review Board for Biomedical Research. Fifteen pairs of subjects, each consisting of one subject with schizophrenia individually matched to one control subject for sex, and as closely as possible for age and post-mortem interval (PMI), were used in this study. The demographic and clinical details of each subject have been previously reported, 23 and the characteristics of the subject groups are summarized in Table 1 . The subject groups did not differ in mean age, PMI, brain pH, RNA integrity number (RIN; assessed by Agilent Bioanalyzer) or tissue storage time.
Consensus DSM-IV 24 diagnoses were made for each subject by an independent committee of experienced research clinicians based on information obtained from medical records and structured interviews conducted with family members. One control subject had a history of depressive disorder (not otherwise specified) and another control subject met criteria for alcohol abuse at the time of death. A history of substance abuse (including alcohol) or dependence disorder was present in eight schizophrenia subjects, with four subjects meeting criteria at time of death. Three control subjects had positive plasma alcohol levels (0.01-0.06%) at the time of death. Toxicology studies did not reveal the presence of substances of abuse in any other subjects. Two schizophrenia subjects had not been on antipsychotic medications for 9.6 and 1.2 months before time of death, and another subject had been off antipsychotic medications for an unknown period of time. The mean age (7s.d.) at the onset of illness was 25.179.0 years, with an average duration of 18.779.4 years, in the subjects with schizophrenia. Because the subject population was community-based, most subjects (12 with schizophrenia and 14 controls) died suddenly outside of a hospital.
Neuropathological examination of each brain revealed that subject 622 had an infarction limited to the distribution of the inferior branch of the right middle cerebral artery, but DLPFC area 9 appeared to be unaffected. Alzheimer's disease was excluded in each subject on the basis of clinical and neuropathological criteria. 25 
Tissue preparation
The right hemisphere from each brain specimen was blocked coronally, frozen and stored at À801C Cryostat sections (20 mm) were cut, thaw-mounted on Super-frost slides (VWR Scientific, West Chester, PA, USA) and returned to À801C until hybridization. Right DLPFC area 9 was examined in this study, with the cytoarchitectonic borders determined from adjacent Nissl-stained sections as previously described. 26 For each mRNA, three in situ hybridization runs were performed, with each run containing one section per subject pair and with the sections from each pair processed in tandem. Across runs, the tissue sections were evenly spaced at 400 mm.
In situ hybridization procedures Riboprobe templates were synthesized by PCR. Specific primers were designed to amplify a 324 base pair . Sequencing revealed that all fragments had 100% homology to the reported nucleotide sequence. The fragments were subcloned into the plasmid pSTBlue-1 (Novagen, Madison, WI, USA). T7 and SP6 polymerase were used to transcribe the sense and antisense probes in vitro in the presence of 35 S-CTP (Amersham Biosciences, Piscataway, NJ, USA). Riboprobes were purified using RNeasy mini spin columns (Qiagen, Valencia, CA, USA) and then alkaline hydrolyzed to reduce the length to approximately 100 bp to allow for more effective penetration of tissue.
Hybridization was performed as previously described. 23 For each run, sections were fixed in 4% paraformaldehyde in phosphate-buffered saline, acetylated with 0.25% acetic anhydrate in 0.1 M triethanolamine/0.9% NaCl for 10 min, dehydrated through a graded ethanol series, and defatted in chloroform for 10 min. Hybridization was then performed with, 35 S-labeled riboprobes (2 Â 10 7 d.p.m./ ml) in hybridization buffer containing 50% formamide, 0.75 M NaCl, 20 mM 1,4-piperazine diethane sulfonic acid, pH 6.8, 10 mM EDTA, 10% dextran sulfate, 5X Denhardt's solution, 50 mM dithiothreitol, 0.2% SDS and 100 mg/ml yeast tRNA at 561C for 16-20 h. The sections were stringently washed in a solution containing 0.3 M NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0, and 50% formamide at 63.51C treated with RNase A (20 mg/ml) at 371C and then washed in 0.1 Â SSC (150 mM Nacl, 15 mM sodium citrate) at 65.51C. Sections were then dehydrated through a graded alcohol series, air-dried and exposed to BioMax MR film (Kodak, Rochester, NY, USA) for the appropriate length of time (3-5 days), which was determined by test sections for each probe. After the development of the autoradiographs, sections were coated with NTB2 emulsion (Kodak, Rochester, NY, USA) diluted 2:1 with water. A mechanical dipper, Auto-dip Emulsion Coater (Ted Pella, Redding, CA, USA), was used to provide a consistent layer of emulsion on the section. The length of exposure to the emulsion was determined by the development of test sections that were processed in tandem. After development of film emulsion, sections were counterstained with cresyl violet. For all steps, sense riboprobes were also processed to confirm the specificity of the antisense riboprobes.
Quantification
Film images of autoradiographs were captured by a video camera, digitized and analyzed utilizing a Microcomputer Imaging Device system (Imaging Research Inc., London, ON, Canada). The acquired images were coded so that the investigator (JH) was blind to diagnosis and subject number. The contours of the gray and white matter were delineated on each autoradiograph by superimposing the digital image of an adjacent Nissl-stained section. The optical density was determined in as large an area as possible in each region of interest (i.e., entire thickness of the cortical gray matter and in the underlying white matter) on each autoradiograph and expressed as nanocuries per gram tissue by reference to radioactive carbon-14 standards (American Radioactive Chemicals, St Louis, MO, USA) exposed on the same film. To determine the laminar specificity of mRNA expression, three cortical transverses, each with a width of 1-2 mm, were sampled per section. All sampled transverses were located in portions of the tissue section cut perpendicular to the pial surface as determined by the presence of pyramidal neurons with vertically oriented apical dendrites on the adjacent Nissl-stained sections. The expression of the mRNAs within layers 1, deep 3 and 6 was determined by measuring optical density in zones located 0-10, 30-50 or 80-100%, respectively, from the pial surface to the white matter border. 27 In order to approximate the expression level of each mRNA in pyramidal neurons, the measured optical density in layer 1 (which contains glial cells and interneurons, but essentially no pyramidal neurons) was subtracted from the optical density measures of the total gray matter and of layers deep 3 and 6.
Antipsychotic-treated monkeys In order to examine the possible effects of chronic antipsychotic medication exposure on the expression of Cdc42 and Duo mRNAs, 18 experimentally naïve male macaque monkeys (Macaca fascicularis), 4.5-5.3 years of age, were arbitrarily divided into three groups and trained to take orally pellets containing either haloperidol, olanzapine or sham twice a day. 28 At steady state, the total daily dose of drug per animal ranged from 28 to 32 mg for haloperidol and 11.0 to 13.2 mg for olanzapine. These doses produced trough serum levels of B1.5 ng/ml for haloperidol and B15 ng/ml for olanzapine, levels in the therapeutic range for the treatment of schizophrenia in humans. After 17-27 months of drug exposure, animals (grouped into triads by body weight) were deeply anesthetized, the brains were removed, and the right hemisphere was blocked, frozen and stored at À801C. All procedures were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the University of Pittsburgh Institutional Animal Care and Use Committee.
Processing of monkey brain specimens for in situ hybridization was conducted as described above with the following exceptions. Serial cryostat sections (16 mm) were cut from fresh frozen tissue blocks containing the middle one-third of the principal sulcus. Two sets of adjacent sections from each animal, spaced at 224 mm, were used for analysis of the expression of Cdc42 and Duo mRNAs in the dorsal bank of the principal sulcus, corresponding to DLPFC area 46.
Statistical analyses
The effects of diagnosis on the mRNA expression levels were tested by analysis of covariance (ANCO-VA) models 29 using the mean values across the three sections from each subject for each mRNA. The first ANCOVA model had diagnostic group as a main effect, subject pair as a blocking effect, and brain pH as a covariate. The inclusion of subject pair reflects the matching of individual subject pairs for sex, age and PMI. Post-mortem brain pH was included as a covariate because it may reflect the integrity of some mRNA species. 30 Tissue storage time was initially included in the model, but because a significant effect of storage time on mRNA expression was never observed, this term was excluded from the final ANCOVA model. Subject pairing may be considered an attempt to balance the two diagnostic groups with regard to the experimental factors instead of a true statistical paired design. Thus, a second ANCOVA model was performed with a main effect of diagnostic group; age, PMI and brain pH as covariates; and sex as a blocking factor for the purpose of error variance reduction. Because these two ANCOVAs produced similar results, only the results from the second analyses are reported.
Pearson's correlation analyses were performed between mRNA expression level and spine density on deep layer 3 and layers 5 and 6 pyramidal neurons 5, 30 for the 12 subjects shared across studies. In order to determine whether differences in mRNA expression levels between schizophrenia and control subjects differed as a function of cortical layer, the differences in expression between layers deep 3 and 6 within each subject were compared between subject groups using both paired t-tests and ANCOVAs with diagnosis as the between-subjects factor; layer as the within-subjects factor; age, PMI and pH as covariates; and sex as a blocking factor. For the antipsychotictreated monkeys, a single-factor ANOVA model was used with triad as the blocking factor and treatment group as the main effect.
All statistical tests were conducted with an alevel = 0.05. The Bonferroni correction was used to correct for multiple comparisons.
Results
Expression pattern of mRNAs in human DLPC area 9
The cellular expression pattern for each mRNA probe was determined by examination of grain accumulation in relation to Nissl-stained nuclei on emulsion-coated slides (Figure 1 ). In the Nissl stain, neurons were characterized by the faint staining of their large nuclei, whereas glia cells were distinguished by their intensely stained, small nuclei. Positive hybridization of a cell was indicated by silver grain clustering around a Nissl-stained nucleus, indicating hybridization of the probe within the cytoplasm. For Cdc42, Rac1 and RhoA mRNAs, grain accumulation was evident over multiple cell types (Figure 1a-c) . The largest cell type present, putatively pyramidal neurons, showed the heaviest accumulation. Medium-sized nuclei, typically interneurons, also showed positive labeling of grain accumulation, as did small, intensely stained nuclei, presumably glia. For Duo and drebrin, grain accumulation appeared to be confined to the largest nuclei present, presumably pyramidal neurons, and was not identified over smaller stained nuclei (Figure 1d-e) . The specificity of each of the five antisense riboprobes was confirmed by the absence both of grain clustering and of signal above background in sections treated with the sense riboprobes for these mRNAs.
For all five probes, expression was clearly present in cortical layers 2-6 ( Figure 2, left column) . For Cdc42, Rac1, RhoA, expression was faint in layer 1, exhibited a uniform expression pattern across layers 2-6 and was present to a lesser extent in the white matter. In contrast, expression for Duo and drebrin mRNAs was observed only in layers 2-6; in some subjects, the expression of these two mRNAs appeared to be slightly lower in layer 4 than in the adjacent layers. These laminar patterns of expression were similar in the subjects with schizophrenia ( Figure 2, right column) .
Analysis of mRNA expression in area 9 in schizophrenia and control subjects In measures made through the entire cortical gray matter (Figure 3) , the mean (7s.d.) level of Cdc42 mRNA expression was significantly (F (1,24) = 11.8,. P = 0.002) decreased by 21% in the subjects with schizophrenia (65.4716.7 nCi/g) relative to matched controls (83.0711.9 nCi/g); for Rac1 mRNA, a nonsignificant (F (1,24) = 2.34, P = 0.14) decrease of 12% was detected between subjects with schizophrenia (64.5714.5 nCi/g) and matched controls (73.57 18.3 nCi/g); and RhoA mRNA showed a significant (F (1,24) = 4.64, P = 0.04) 18% decrease in expression in the schizophrenia subjects (50.1717.1 nCi/g) relative to controls (61.4712.4 nCi/g). In addition, expression in the white matter was significantly decreased for both Rac1 (F (1,24) = 8.3, P = 0.008) and RhoA (F (1,24) = 13.1, P = 0.001) mRNAs by 14 and 29%, respectively, in the subjects with schizophrenia. Whether these differences reflect fewer glial cells, 31 and/or reduced expression of these transcripts per cell, cannot be determined from the present study.
The mean level of Duo mRNA expression in the gray matter was significantly (F (1,24) = 7.2, P = 0.013) decreased by 13% in the schizophrenia subjects (93.0719.1 nCi/g) compared to controls (107.5 nCi/g), and a significant (F (1,24) = 4.8, P = 0.038) decrease of 16% in drebrin mRNA was observed in schizophrenia subjects (64.4717.2 nCi/g) relative to matched controls (76.379.4 nCi/g). When the measures in the gray matter were subjected to a Bonferroni correction for multiple comparisons, only the changes in Cdc42 and Duo mRNAs retained significance.
Correlation of spine density with mRNA expression Given the previous reports of a reduction in spine density in subjects with schizophrenia, it was important to determine whether, within the same subjects, the expression levels of these mRNAs were correlated with spine density on deep layer 3 pyramidal neurons in an adjacent region of the DLPFC. In the 12 subjects (seven controls and five schizophrenia subjects) common to both this study and our previous study of spine density, 5 significant correlations were observed between spine density and the expression levels of Cdc42 (r = 0.71, P = 0.009) and Duo (r = 0.73, P = 0.007) mRNAs, but not for the expression of Rac1 (r = 0.51, P = 0.09), RhoA (r = 0.53, P = 0.08) or drebrin (r = 0.33, P = 0.29) mRNAs. In contrast, in layers 5 and 6, where no decrements in spine density were observed in subjects with schizophrenia, 30 neither Cdc42 (r < 0.18; P > 0.58) nor Duo (r < 0.20; P > 0.54) mRNA expression levels were significantly correlated with spine density.
Laminar analysis of mRNA expression
In our previous studies of spine density in the DLPFC of subjects with schizophrenia 5, 32 , the reduction in spine density was present in deep layer 3, but not in layer 6. Therefore, we sought to determine whether the decrease in Cdc42 or Duo mRNAs was greater in deep layer 3 than in layer 6 (see Table 2 ). The mean (7s.d.) difference in expression between deep layer 3 and layer 6 for Cdc42 did not differ (t = À0.38, P = 0.35) between control (15.270.11 nCi/g) and schizophrenia (16.870 .07 nCi/g) subjects. Similarly, the laminar difference in Duo mRNA expression did not differ (t = À0.64, P = 0.27) between control (À1.870.07 nCi/g) and schizophrenia (0.1970.07 nCi/g) subjects. Consistent with these analyses, ANCOVAs revealed that the interaction between diagnosis and layer was not significant for either Cdc42 (F (1, 24) = 0.13, P = 0.72) or Duo (F (1,24) = 0.29, P = 0.60).
Analysis of mRNA expression in monkeys exposed to antipsychotic medications In order to determine whether the alterations in mRNA expression observed in the subjects with schizophrenia might reflect the effects of chronic treatment with antipsychotic medications, we examined mRNA expression in tissue from monkeys chronically exposed to haloperidol, olanzapine or sham (Figure 4) . Neither the expression of Cdc42 mRNA (F (2,15) = 0.03, P = 0.97) nor of Duo mRNA (F (2, 15) = 0.1, P = 0.91) differed across these three groups of animals ( Figure 5 ).
Discussion
The results of this study demonstrate that the expression levels of certain mRNAs encoding proteins known to be key regulators of pyramidal neuron dendritic spines are reduced in the DLPFC of subjects with schizophrenia. Of the five transcripts examined, only the mRNAs for Cdc42 and Duo (1) showed significantly decreased expression levels in the cortical gray matter of schizophrenia subjects when corrected for multiple comparisons, (2) had expression levels that were significantly correlated with spine density in the same subjects and (3) did not exhibit decreased expression in the white matter. These findings suggest that reduced expression of Cdc42 and Duo mRNAs represent intracellular mechanisms that might contribute to the decreased density of dendritic spines observed in the DLPFC in schizophrenia, although further studies at the cellular level are required.
Several lines of evidence suggest that these alterations in mRNA expression reflect the disease process of schizophrenia and are not due to chronic treatment with antipsychotic medications or other potential confounds. First, no alterations in the expression of Cdc42 or Duo mRNAs were detected in monkeys chronically exposed to either typical or atypical antipsychotic medications. The Cdc42 comparisons were adequately powered (b = 0.77-0.88) to detect differences of the magnitude observed in the human studies, whereas the power of the Duo comparisons was lower (b = 0.37-0.47). In addition, the three subjects with schizophrenia who were free of antipsychotic medications at the time of death still showed decreased expression of Cdc42 and Duo mRNAs relative to their matched controls. These findings appear to be consistent with a previous report that the expression of spinophilin mRNA, a protein present in most dendritic spines, was unchanged in rats exposed to antipsychotic medications. 33 Second, the observed decrease in mRNA expression in the subjects with schizophrenia does not appear to reflect a general decline in RNA integrity in these subjects because (1) their brain pH and RIN values were in the range known to be associated with sudden death and good RNA preservation 30 and (2) similar studies in the same subjects with schizophrenia demonstrated no differ- Figure 2 Representative film autoradiograms illustrating the expression of Cdc42, Rac1, RhoA, Duo and drebrin mRNAs in DLPFC area 9 of a control subject and an age-, sex-and PMI-matched subject with schizophrenia. The intensities of the hybridization signals are presented in pseudocolor manner according to the calibration scales (right) for each mRNA. Expression levels of each mRNA are reduced in the schizophrenia subject compared with matched control. Solid and broken lines indicate the pial surface and the border between gray and white matter, respectively. Scale bars = 1.0 mm and apply to all panels. ences between subject groups in the expression levels of a number of other mRNAs. 23, 34 Given previous studies indicating that the presence of Cdc42 and Duo are essential for a normal complement of dendritic spines, [13] [14] [15] 18, 20 reduced expression of the mRNAs for these proteins would be expected to be associated with a decrease in dendritic spine density. Cdc42 regulates the polymerization of the actin cytoskeleton into filopodia, 14 many of which are precursors for mature spines. 35 Thus, reduced levels of Cdc42 might impair the ability of pyramidal neurons to generate new filopodia in the adult neocortex. Furthermore, the formation of spines is closely tied to the generation of stable constructs of the actin cytoskeleton.
14 This stability is regulated by Rac1, whose upstream regulator is Duo. 36 Therefore, a decrease in Duo mRNA expression would result in reduced activation of Rac1, and consequently impaired stability of dendritic spines. Taken together, a decrease in the expression of both Cdc42 and Duo mRNAs would be expected to result in a reduction in the formation of new spines and an impairment in the maintenance of existing, mature spines. Although it is tempting to extrapolate these findings to earlier periods of brain development, unfortunately they do not directly address the hypotheses of deficient spinogenesis during the perinatal period versus excessive spine pruning during adolescence as the proximal events to decreased spine and synaptic density in adult individuals with schizophrenia. 37 Our previous studies of subjects with schizophrenia showed a significant 23% decrease in spine density on the basilar dendrites of deep layer 3 pyramidal neurons, but no change in spine density on the basilar dendrites of pyramidal neurons located in layer 5 or 6. 5, 32 Given these observations, we predicted that the decreased expression of Cdc42 and Duo mRNAs in schizophrenia would be greater in deep layer 3 than in layer 6, reflecting the laminarspecific decrement in spine density. However, the level of mRNA expression in deep layer 3 relative to layer 6 within each subject was not significantly lower in the subjects with schizophrenia than in the control subjects. This observation suggests that the decreased expression of Cdc42 and Duo mRNAs in schizophrenia is not a secondary consequence of a reduced number of pyramidal neuron dendritic spines, since the expression of these mRNAs was similarly reduced in layers with or without a reduction in spine density. The decreased expression of Cdc42 and Duo mRNAs across cortical layers also suggests that reduced expression of Cdc42 and Duo mRNAs might contribute to, but not be sufficient to cause, reduced spine density. Thus, an additional alteration in the DLPFC of subjects with schizophrenia, that is present in deep layer 3 but not in layer 6, might be required to produce the laminar-specific reduction in spine density. For example, excitatory synaptic activity can increase the formation of new spines, in addition to changing the shape of existing spines. 36, 38 Thus, a laminar-specific reduction in excitatory inputs might interact with alterations in the molecular cascades involving Cdc42 and Duo to produce a reduction in spine density in schizophrenia. For example, the excitatory inputs from the medial dorsal thalamic nucleus (MD) synapse primarily on dendritic spines 39 and densely arborize in DLPFC layers deep 3 and 4, but do not innervate the deep cortical layers. 40 Interestingly, functional imaging studies have reported altered activation of the MD during working memory tasks in subjects with schizophrenia. 41 In addition, initial post-mortem studies reported a decrement in the number of MD neurons in subjects with schizophrenia, [42] [43] [44] [45] although more recent studies have failed to confirm this finding. [46] [47] [48] Alternatively, the intrinsic axon collaterals of layer 3 pyramidal neurons, which arborize in distinct stripe-like clusters that are restricted to the supragranular layers (in contrast to the inputs from other cortical regions which arborize across all cortical layers), 49 could also serve as a laminar-specific source of alterations in excitatory inputs to dendritic spines. Thus, since NMDA receptor stimulation is required for the formation of new spines, 38 a reduction in signaling via NMDA receptors by either of these excitatory inputs to layer 3 in subjects with schizophrenia could provide the additional factor required for the reduction in spine density in this laminar location. Although speculative, this interpretation suggests the testable hypothesis that spine density is decreased on the portions of the apical dendrites of pyramidal neurons in layers 5 or 6 that pass through layer deep 3, while being unaltered on the basilar dendrites of the same neurons ( Figure 6 ). Note that the laminar pattern of Duo mRNA expression in the deep layers appears to differ from that present in human subjects (compare to Figure 3d ). Scale bars = 1.0 mm and apply to all panels.
In conclusion, the findings of this study suggest that reduced expression of Cdc42 and Duo mRNAs might contribute to the reduction in dendritic spine density in the DLPFC of subjects with schizophrenia by both impairing the formation of new spines and decreasing the stability of mature spines. Additional studies will be required to determine the factors that give rise to the altered expression of these transcripts in schizophrenia. It must also be kept in mind that other molecular cascades contribute to the regulation of the actin cytoskeleton, 36 and their potential role in the reduced density of dendritic spines in schizophrenia remains to be determined. Figure 6 Schematic diagram summarizing the hypothesized relationship between reduced expression of Cdc42 and Duo mRNAs and reduced inputs from the MD nucleus of the thalamus or the intrinsic axon collaterals of layer 3 pyramidal neurons in producing the apparent laminarspecific reduction in dendritic spine density on the basilar dendrites of deep layer 3 pyramidal neurons in subjects with schizophrenia. As illustrated in the figure, the apical dendrites of pyramidal neurons in layer 6 that extend through the thalamic termination zone are predicted to show a reduction in spine density that is similar to that observed on the basilar dendrites of pyramidal neurons in deep layer 3. Note that in contrast to the laminarly restricted termination of excitatory inputs from the thalamus and intrinsic axon collaterals, those originating in other cortical association regions tend to terminate across all cortical layers.
